HighTower Advisors
RCPI

HighTower Advisors’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

HighTower Advisors’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,305
Closed -$6K – 1839
2015
Q1 		$6K Buy
+2,305
New +$9.07K ﹤0.01% 1602

Other funds holding RCPI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HighTower Advisors's RCPI Position: Q2 2015 in Review

HighTower Advisors sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q2 2015, closing a stake of 2,305 shares — an estimated $6K sold.

HighTower Advisors first reported a position in RCPI in Q1 2015 and held it in 1 quarter. The position peaked at $6K in Q1 2015. 36 funds tracked by Wall St. Rank hold RCPI as of Q2 2015.

  • HighTower Advisors reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • HighTower Advisors sold 2,305 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $6K.
  • HighTower Advisors first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • HighTower Advisors's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $6K in Q1 2015.
  • 36 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on HighTower Advisors's 13F filing for Q2 2015, filed 11 Aug 2015.